Patient Story
A pinpoint treatment
An active 81-year-old fights prostate cancer—twice—and emerges grateful for the care and kindness he received.
An active 81-year-old fights prostate cancer—twice—and emerges grateful for the care and kindness he received.
Experts say a landmark study has found certain gene mutations can be targeted with newer drug therapies.
If you’re a guy, you probably have some theories about testosterone, erectile dysfunction and the like. Now’s your chance to test them.
Researchers examine falloff after change in prostate cancer screening recommendations.